These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19967742)

  • 1. Induced adult stem (iAS) cells and induced transit amplifying progenitor (iTAP) cells-a possible alternative to induced pluripotent stem (iPS) cells?
    Heng BC; Richards M; Ge Z; Shu Y
    J Tissue Eng Regen Med; 2010 Feb; 4(2):159-62. PubMed ID: 19967742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
    Tokumoto Y; Ogawa S; Nagamune T; Miyake J
    J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming adult hematopoietic cells.
    Kaneko S; Otsu M; Nakauchi H
    Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viable iPSC mice: a step closer to therapeutic applications in humans?
    Betts DH; Kalionis B
    Mol Hum Reprod; 2010 Feb; 16(2):57-62. PubMed ID: 19952032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of an operationally-defined neural stem cell clone.
    Parker MA; Anderson JK; Corliss DA; Abraria VE; Sidman RL; Park KI; Teng YD; Cotanche DA; Snyder EY
    Exp Neurol; 2005 Aug; 194(2):320-32. PubMed ID: 15992799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
    Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
    Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of murine hepatic lineage cells from induced pluripotent stem cells.
    Gai H; Nguyen DM; Moon YJ; Aguila JR; Fink LM; Ward DC; Ma Y
    Differentiation; 2010 Mar; 79(3):171-81. PubMed ID: 20106584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation.
    Hu Q; Friedrich AM; Johnson LV; Clegg DO
    Stem Cells; 2010 Nov; 28(11):1981-91. PubMed ID: 20882530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non cell-autonomous reprogramming of adult ocular progenitors: generation of pluripotent stem cells without exogenous transcription factors.
    Balasubramanian S; Babai N; Chaudhuri A; Qiu F; Bhattacharya S; Dave BJ; Parameswaran S; Carson SD; Thoreson WB; Sharp JG; Rao M; Ahmad I
    Stem Cells; 2009 Dec; 27(12):3053-62. PubMed ID: 19859985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells.
    Mizuno Y; Chang H; Umeda K; Niwa A; Iwasa T; Awaya T; Fukada S; Yamamoto H; Yamanaka S; Nakahata T; Heike T
    FASEB J; 2010 Jul; 24(7):2245-53. PubMed ID: 20181939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
    Tonti GA; Mannello F
    Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.